AR217041A1 - Procedimiento para la preparacion de derivados de aminoacidos n-(4-halo-o nitro-2-benzoil-o-monohalobenzoil o picolinoil)glicinamidas y los correspondientes 2-(3-aminometil-4h-1,2,4-triazol-4-il)y 2-(5-aminometil-1-imidazolil) - Google Patents

Procedimiento para la preparacion de derivados de aminoacidos n-(4-halo-o nitro-2-benzoil-o-monohalobenzoil o picolinoil)glicinamidas y los correspondientes 2-(3-aminometil-4h-1,2,4-triazol-4-il)y 2-(5-aminometil-1-imidazolil)

Info

Publication number
AR217041A1
AR217041A1 AR260048A AR26004875A AR217041A1 AR 217041 A1 AR217041 A1 AR 217041A1 AR 260048 A AR260048 A AR 260048A AR 26004875 A AR26004875 A AR 26004875A AR 217041 A1 AR217041 A1 AR 217041A1
Authority
AR
Argentina
Prior art keywords
aminometil
picolinoil
monohalobenzoil
imidazolil
glycinamides
Prior art date
Application number
AR260048A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR217041A1 publication Critical patent/AR217041A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
AR260048A 1974-08-20 1975-08-19 Procedimiento para la preparacion de derivados de aminoacidos n-(4-halo-o nitro-2-benzoil-o-monohalobenzoil o picolinoil)glicinamidas y los correspondientes 2-(3-aminometil-4h-1,2,4-triazol-4-il)y 2-(5-aminometil-1-imidazolil) AR217041A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB36567/74A GB1517164A (en) 1974-08-20 1974-08-20 Substituted-phenyl ketones and a process for the manufacture thereof
GB2182175 1975-05-21

Publications (1)

Publication Number Publication Date
AR217041A1 true AR217041A1 (es) 1980-02-29

Family

ID=26255542

Family Applications (1)

Application Number Title Priority Date Filing Date
AR260048A AR217041A1 (es) 1974-08-20 1975-08-19 Procedimiento para la preparacion de derivados de aminoacidos n-(4-halo-o nitro-2-benzoil-o-monohalobenzoil o picolinoil)glicinamidas y los correspondientes 2-(3-aminometil-4h-1,2,4-triazol-4-il)y 2-(5-aminometil-1-imidazolil)

Country Status (19)

Country Link
JP (1) JPS6018656B2 (fr)
AR (1) AR217041A1 (fr)
AT (1) AT348985B (fr)
AU (1) AU502104B2 (fr)
CA (1) CA1177069A (fr)
CH (1) CH620900A5 (fr)
DD (1) DD123086A5 (fr)
DE (1) DE2537069A1 (fr)
DK (1) DK149284C (fr)
ES (1) ES440315A1 (fr)
FI (1) FI66592C (fr)
FR (1) FR2282261A1 (fr)
GB (1) GB1517164A (fr)
IL (1) IL47936A (fr)
LU (1) LU73219A1 (fr)
NL (1) NL7509884A (fr)
NO (1) NO150199C (fr)
PH (1) PH16616A (fr)
SE (1) SE426319B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2754112A1 (de) * 1977-12-05 1979-06-13 Kali Chemie Pharma Gmbh 1,4-benzodiazepinderivate, ihre salze und diese verbindungen enthaltende arzneipraeparate
IN184976B (fr) * 1996-06-13 2000-10-14 Ranbaxy Lab Ltd

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3709898A (en) * 1971-02-09 1973-01-09 Upjohn Co Process for the production of triazolobenzodiazepines and intermediates
JPS526861B2 (fr) * 1972-05-27 1977-02-25
ZA735932B (en) * 1972-09-21 1974-07-31 Hoffmann La Roche Benzodiazepine derivatives

Also Published As

Publication number Publication date
ATA642175A (de) 1978-08-15
NL7509884A (nl) 1976-02-24
NO150199C (no) 1984-09-05
ES440315A1 (es) 1977-09-16
SE426319B (sv) 1982-12-27
IL47936A0 (en) 1975-11-25
LU73219A1 (fr) 1977-04-15
PH16616A (en) 1983-11-28
CH620900A5 (en) 1980-12-31
FI66592B (fi) 1984-07-31
FR2282261A1 (fr) 1976-03-19
DE2537069A1 (de) 1976-03-04
FR2282261B1 (fr) 1978-11-10
CA1177069A (fr) 1984-10-30
AU8407475A (en) 1977-02-24
NO752876L (fr) 1976-02-23
DK373975A (da) 1976-02-21
DK149284B (da) 1986-04-21
JPS51125048A (en) 1976-11-01
IL47936A (en) 1980-01-31
AT348985B (de) 1979-03-12
AU502104B2 (en) 1979-07-12
NO150199B (no) 1984-05-28
DK149284C (da) 1986-10-13
SE7509268L (sv) 1976-02-23
JPS6018656B2 (ja) 1985-05-11
FI66592C (fi) 1984-11-12
GB1517164A (en) 1978-07-12
DD123086A5 (fr) 1976-11-20
FI752350A (fr) 1976-02-21
DE2537069C2 (fr) 1988-09-08

Similar Documents

Publication Publication Date Title
AR209457A1 (es) Procedimiento para la preparacion de nuevas sales de biguanidas
AR205196A1 (es) Procedimiento de preparacion de derivados de acidos n n'-bis(triiodocarbamoil - amino - benzoil)-diamino-alcanoicos
AR207442A1 (es) Procedimiento de preparacion de n-(cumaranil-5-metil)-n'-(triazolil-2)-piperazinas
AR215886A1 (es) Procedimiento para la preparacion de derivados de n-(5-tetrazolil)-4-oxo-4h-pirimido(2,1-b)benzotiazol y sales de los mismos
AR208562A1 (es) Procedimiento para la preparacion de derivados de 4a-fenilcis-decahidroisoquinolina
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
ES454087A2 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona nuevas.
AR216043A1 (es) Procedimiento para la preparacion de 1-derivados de benzoilamino-4-piperidina y sus sales fisiologicamente aceptables
MX3514E (es) Procedimiento para la preparacion de derivados de 1,3 tiazolidinas
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
MX4586E (es) Procedimiento para la preparacon de n-(4-benciloxifenil) n'-metil-n'-metoxiurea
AR218436A1 (es) Procedimiento para la preparacion de derivados de 2(o 4)-hidroxipolihaloisopropil fenil ureas
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
AR214985A1 (es) Procedimiento para la elaboracion de 4-7-bromo-5-metoxi-2-benzofuranil)-piperidina y sus sales de adicion de acidos
AR217041A1 (es) Procedimiento para la preparacion de derivados de aminoacidos n-(4-halo-o nitro-2-benzoil-o-monohalobenzoil o picolinoil)glicinamidas y los correspondientes 2-(3-aminometil-4h-1,2,4-triazol-4-il)y 2-(5-aminometil-1-imidazolil)
DK434675A (da) Fremgangsmade til fremstilling af 4-oxo-4h-pyrano-(3,2-c)-chinolin-2-carboxylsyrer og salte heraf
AR205739A1 (es) Procedimiento para la preparacion de derivados de diteofilina
MX3630E (es) Procedimiento para la preparacion de derivados de fosforotiolato
AR206624A1 (es) Procedimiento para la preparacion de derivados de 1,2,6,7-tetrahidro-2-metil-1-(2-(metil o etil)-aminoetil)-indolo-(1,7-ab)(1)benzacepina
MX3519E (es) Procedimiento para la preparacion de n-(1-etil-2-pirrolidilmetil)-2-metoxi-5-sulfamoil benzamida
AR216894A1 (es) Procedimiento para la obtencion de derivados de 1,3-diisocianatopropano y dichos derivados
MX4485E (es) Procedimiento para la preparacion de 2,4-diamino-5-bencil-pirimidinas y sus sales
AR208307A1 (es) Procedimiento para la preparacion de sales de (n-(2-indanil)-anilino)-alquilamonio
AR212635A1 (es) Procedimiento de preparacion de n-(1'-alilpirrolidinil-2'-metil)-2-metoxi-4,5-azimidibenzamida
AR201706A1 (es) Procedimiento para la preparacion de derivados de 3-bencilidenhidrazino-6-(2-hidroxipropil)-aminopiridazina